Artykuły w czasopismach na temat „Adenosine mediated cardioprotection”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Adenosine mediated cardioprotection”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
McIntosh, Victoria J., i Robert D. Lasley. "Adenosine Receptor-Mediated Cardioprotection". Journal of Cardiovascular Pharmacology and Therapeutics 17, nr 1 (18.02.2011): 21–33. http://dx.doi.org/10.1177/1074248410396877.
Pełny tekst źródłaZhan, Enbo, Victoria J. McIntosh i Robert D. Lasley. "Adenosine A2A and A2B receptors are both required for adenosine A1 receptor-mediated cardioprotection". American Journal of Physiology-Heart and Circulatory Physiology 301, nr 3 (wrzesień 2011): H1183—H1189. http://dx.doi.org/10.1152/ajpheart.00264.2011.
Pełny tekst źródłaLIANG, Bruce T. "Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotection". Biochemical Journal 336, nr 2 (1.12.1998): 337–43. http://dx.doi.org/10.1042/bj3360337.
Pełny tekst źródłaWILLEMS, L., K. ASHTON i J. HEADRICK. "Adenosine-mediated cardioprotection in the aging myocardium". Cardiovascular Research 66, nr 2 (1.05.2005): 245–55. http://dx.doi.org/10.1016/j.cardiores.2004.11.008.
Pełny tekst źródłaPeart, Jason, Amanda Flood, Joel Linden, G. Paul Matherne i John P. Headrick. "Adenosine-Mediated Cardioprotection in Ischemic-Reperfused Mouse Heart". Journal of Cardiovascular Pharmacology 39, nr 1 (styczeń 2002): 117–29. http://dx.doi.org/10.1097/00005344-200201000-00013.
Pełny tekst źródłaKurz, Michael A., David A. Bullough, Christopher J. L. Buggé, Kevin M. Mullane i Mark A. Young. "Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine". European Journal of Pharmacology 322, nr 2-3 (marzec 1997): 211–20. http://dx.doi.org/10.1016/s0014-2999(97)00011-3.
Pełny tekst źródłaPeart, Jason, i John Headrick. "Mechanisms of adenosine-mediated cardioprotection in the murine heart". Journal of Molecular and Cellular Cardiology 33, nr 6 (czerwiec 2001): A91. http://dx.doi.org/10.1016/s0022-2828(01)90363-3.
Pełny tekst źródłaPeart, Jason, Laura Willems i John P. Headrick. "Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine". American Journal of Physiology-Heart and Circulatory Physiology 284, nr 2 (1.02.2003): H519—H527. http://dx.doi.org/10.1152/ajpheart.00717.2002.
Pełny tekst źródłaCaricati-Neto, Afonso, Paolo Ruggero Errante i Francisco Sandro Menezes-Rodrigues. "Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection". International Journal of Molecular Sciences 20, nr 16 (16.08.2019): 4002. http://dx.doi.org/10.3390/ijms20164002.
Pełny tekst źródłaWakeno-Takahashi, Mayu, Hajime Otani, Shinichi Nakao, Yuka Uchiyama, Hiroji Imamura i Koh Shingu. "Adenosine and a Nitric Oxide Donor Enhances Cardioprotection by Preconditioning with Isoflurane through Mitochondrial Adenosine Triphosphate-sensitive K+Channel-dependent and -independent Mechanisms". Anesthesiology 100, nr 3 (1.03.2004): 515–24. http://dx.doi.org/10.1097/00000542-200403000-00009.
Pełny tekst źródłaTracey, W. Ross, William P. Magee, Joseph J. Oleynek, Roger J. Hill, Andrew H. Smith, David M. Flynn i Delvin R. Knight. "NovelN6-substituted adenosine 5′-N-methyluronamides with high selectivity for human adenosine A3receptors reduce ischemic myocardial injury". American Journal of Physiology-Heart and Circulatory Physiology 285, nr 6 (grudzień 2003): H2780—H2787. http://dx.doi.org/10.1152/ajpheart.00411.2003.
Pełny tekst źródłaEmanuelov, Avishag K., Asher Shainberg, Yelena Chepurko, Doron Kaplan, Alex Sagie, Eyal Porat, Michael Arad i Edith Hochhauser. "Adenosine A3 receptor-mediated cardioprotection against doxorubicin-induced mitochondrial damage". Biochemical Pharmacology 79, nr 2 (styczeń 2010): 180–87. http://dx.doi.org/10.1016/j.bcp.2009.08.010.
Pełny tekst źródłaMiyamae, Masami, S. Albert Camacho, Hui-Zhong Zhou, Ivan Diamond i Vincent M. Figueredo. "Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats". American Journal of Physiology-Heart and Circulatory Physiology 275, nr 1 (1.07.1998): H50—H56. http://dx.doi.org/10.1152/ajpheart.1998.275.1.h50.
Pełny tekst źródłaKersten, Judy R., Karl G. Orth, Paul S. Pagel, David A. Mei, Garrett J. Gross i David C. Warltier. "Role of Adenosine in Isoflurane-induced Cardioprotection". Anesthesiology 86, nr 5 (1.05.1997): 1128–39. http://dx.doi.org/10.1097/00000542-199705000-00017.
Pełny tekst źródłaKristo, G., Y. Yoshimura, B. J. Keith, R. M. Mentzer i R. D. Lasley. "Aged Rat Myocardium Exhibits Normal Adenosine Receptor-Mediated Bradycardia and Coronary Vasodilation But Increased Adenosine Agonist-Mediated Cardioprotection". Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60, nr 11 (1.11.2005): 1399–404. http://dx.doi.org/10.1093/gerona/60.11.1399.
Pełny tekst źródłaThai, B., L. Chia, A. Nguyen, D. Hutchinson, A. Kompa, P. White i L. May. "Adenosine Receptor-Mediated Cardioprotection Post-Myocardial Infarction Associated With Advanced Age". Heart, Lung and Circulation 31 (2022): S68. http://dx.doi.org/10.1016/j.hlc.2022.06.057.
Pełny tekst źródłaHussain, A., P. Karjian i H. Maddock. "The role of nitric oxide in A3 adenosine receptor-mediated cardioprotection". Autonomic and Autacoid Pharmacology 29, nr 3 (lipiec 2009): 97–104. http://dx.doi.org/10.1111/j.1474-8673.2009.00438.x.
Pełny tekst źródłaYao, Z., i G. J. Gross. "Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium." Circulation 88, nr 1 (lipiec 1993): 235–44. http://dx.doi.org/10.1161/01.cir.88.1.235.
Pełny tekst źródłaTorregroza, Carolin, Chiara O. Glashoerster, Katharina Feige, Martin Stroethoff, Annika Raupach, André Heinen, Markus W. Hollmann i Ragnar Huhn. "Mediation of the Cardioprotective Effects of Mannitol Discovered, with Refutation of Common Protein Kinases". International Journal of Molecular Sciences 22, nr 22 (19.11.2021): 12471. http://dx.doi.org/10.3390/ijms222212471.
Pełny tekst źródłaVecchio, E., A. TN Nguyen, C. Tan, P. White i L. May. "A tale of two receptors - Investigating how adenosine A2 receptors modulate adenosine A1 receptor-mediated cardioprotection". Heart, Lung and Circulation 24 (2015): S134. http://dx.doi.org/10.1016/j.hlc.2015.06.050.
Pełny tekst źródłaPeart, Jason N., Garrett J. Gross i John P. Headrick. "15 Ageing impairs ischemic tolerance and adenosine-mediated cardioprotection in murine myocardium". Journal of Molecular and Cellular Cardiology 34, nr 7 (lipiec 2002): A36. http://dx.doi.org/10.1016/s0022-2828(02)90199-9.
Pełny tekst źródłaAshton, Kevin, Kirsty Holmgren, Jason Peart, Sean Grimmon, Paul Matherne i John Headrick. "16 Gene expression profiles involved in ischemic tolerance and adenosine-mediated cardioprotection". Journal of Molecular and Cellular Cardiology 34, nr 7 (lipiec 2002): A36. http://dx.doi.org/10.1016/s0022-2828(02)90200-2.
Pełny tekst źródłaPeart, Jason N., i Garrett J. Gross. "Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors". American Journal of Physiology-Heart and Circulatory Physiology 285, nr 1 (lipiec 2003): H81—H89. http://dx.doi.org/10.1152/ajpheart.00985.2002.
Pełny tekst źródłaHack, Ben D., i John P. Headrick. "Adenosine-mediated cardioprotection is carbon substrate-dependent in the isolated perfused murine heart". Journal of Molecular and Cellular Cardiology 33, nr 6 (czerwiec 2001): A43. http://dx.doi.org/10.1016/s0022-2828(01)90169-5.
Pełny tekst źródłaZhou, Bin, Shaoqing Lei, Rui Xue, Yan Leng, Zhengyuan Xia i Zhong-Yuan Xia. "DJ-1 overexpression restores ischaemic post-conditioning-mediated cardioprotection in diabetic rats: role of autophagy". Clinical Science 131, nr 11 (22.05.2017): 1161–78. http://dx.doi.org/10.1042/cs20170052.
Pełny tekst źródłaLankford, Amy R., Anne M. Byford, Kevin J. Ashton, Brent A. French, Jae K. Lee, John P. Headrick i G. Paul Matherne. "Gene expression profile of mouse myocardium with transgenic overexpression of A1adenosine receptors". Physiological Genomics 11, nr 2 (29.10.2002): 81–89. http://dx.doi.org/10.1152/physiolgenomics.00008.2002.
Pełny tekst źródłaZhao, Ting C., Denise S. Hines i Rakesh C. Kukreja. "Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial KATP channels". American Journal of Physiology-Heart and Circulatory Physiology 280, nr 3 (1.03.2001): H1278—H1285. http://dx.doi.org/10.1152/ajpheart.2001.280.3.h1278.
Pełny tekst źródłaOkada, Takayuki, Hajime Otani, Yue Wu, Takamichi Uchiyama, Shiori Kyoi, Reiji Hattori, Tomohiko Sumida, Hiroyoshi Fujiwara i Hiroji Imamura. "Integrated pharmacological preconditioning and memory of cardioprotection: role of protein kinase C and phosphatidylinositol 3-kinase". American Journal of Physiology-Heart and Circulatory Physiology 289, nr 2 (sierpień 2005): H761—H767. http://dx.doi.org/10.1152/ajpheart.00012.2005.
Pełny tekst źródłaZaugg, Michael, Eliana Lucchinetti, Donat R. Spahn, Thomas Pasch i Marcus C. Schaub. "Volatile Anesthetics Mimic Cardiac Preconditioning by Priming the Activation of Mitochondrial KATPChannels via Multiple Signaling Pathways". Anesthesiology 97, nr 1 (1.07.2002): 4–14. http://dx.doi.org/10.1097/00000542-200207000-00003.
Pełny tekst źródłaIhara, Madoka, Hiroshi Asanuma, Satoru Yamazaki, Hisakazu Kato, Yoshihiro Asano, Yoshihiro Shinozaki, Hidezo Mori i in. "An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury". American Journal of Physiology-Heart and Circulatory Physiology 308, nr 10 (15.05.2015): H1287—H1297. http://dx.doi.org/10.1152/ajpheart.00835.2014.
Pełny tekst źródłaYe, Yumei, Yu Lin, Regino Perez-Polo, Ming-He Huang, Michael G. Hughes, David J. McAdoo, Saraswathy Manickavasagam, Barry F. Uretsky i Yochai Birnbaum. "Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination". American Journal of Physiology-Heart and Circulatory Physiology 293, nr 1 (lipiec 2007): H813—H818. http://dx.doi.org/10.1152/ajpheart.00210.2007.
Pełny tekst źródłaHaessler, Reinhard, Koh Kuzume, Roger A. Wolff, Kazuyo Kuzume, Grace L. Chien, Richard F. Davis i Donna M. Van Winkle. "Adrenergic activation confers cardioprotection mediated by adenosine, but is not required for ischemic preconditioning". Coronary Artery Disease 7, nr 4 (kwiecień 1996): 305–14. http://dx.doi.org/10.1097/00019501-199604000-00007.
Pełny tekst źródłaDing, Mingge, Yin Wang, Di Sun, Zhenhua Liu, Jie Wang, Xing Li, Cong Huo i in. "Punicalagin Pretreatment Attenuates Myocardial Ischemia-Reperfusion Injury via Activation of AMPK". American Journal of Chinese Medicine 45, nr 01 (styczeń 2017): 53–66. http://dx.doi.org/10.1142/s0192415x17500057.
Pełny tekst źródłaWilliams-Pritchard, Grant, Matthew Knight, Louise See Hoe, John P. Headrick i Jason N. Peart. "Essential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioning". American Journal of Physiology-Heart and Circulatory Physiology 300, nr 6 (czerwiec 2011): H2161—H2168. http://dx.doi.org/10.1152/ajpheart.00639.2010.
Pełny tekst źródłaBradamante, Silvia, Livia Barenghi, Franco Piccinini, Alberto A. E. Bertelli, Robert De Jonge, Patricia Beemster i Jan Willem De Jong. "Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism". European Journal of Pharmacology 465, nr 1-2 (marzec 2003): 115–23. http://dx.doi.org/10.1016/s0014-2999(03)01441-9.
Pełny tekst źródłaDel Pozzo, Jaclyn, Puja Mehta, Fei Cai, Cairong Li, Satoru Kobayashi i Qiangrong Liang. "Unexpected Role of Adenosine-Monophosphate Activated Protein Kinase in Doxorubicin Cardiotoxicity and Metformin-Mediated Cardioprotection". Journal of Cardiac Failure 25, nr 8 (sierpień 2019): S2. http://dx.doi.org/10.1016/j.cardfail.2019.07.015.
Pełny tekst źródłaBallard-Croft, Cherry, Gentian Kristo, Yukihiro Yoshimura, Easton Reid, Byron J. Keith, Robert M. Mentzer i Robert D. Lasley. "Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments". American Journal of Physiology-Heart and Circulatory Physiology 288, nr 3 (marzec 2005): H1359—H1366. http://dx.doi.org/10.1152/ajpheart.01006.2004.
Pełny tekst źródłaDrenger, Benjamin, Israel A. Ostrovsky, Michal Barak, Yael Nechemia-Arbely, Ehud Ziv i Jonathan H. Axelrod. "Diabetes Blockade of Sevoflurane Postconditioning Is Not Restored by Insulin in the Rat Heart". Anesthesiology 114, nr 6 (1.06.2011): 1364–72. http://dx.doi.org/10.1097/aln.0b013e31820efafd.
Pełny tekst źródłaTian, Yikui, Bryan A. Piras, Irving L. Kron, Brent A. French i Zequan Yang. "Adenosine 2B Receptor Activation Reduces Myocardial Reperfusion Injury by Promoting Anti-Inflammatory Macrophages Differentiation via PI3K/Akt Pathway". Oxidative Medicine and Cellular Longevity 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/585297.
Pełny tekst źródłaGoyal, A., BC Semwal i HN Yadav. "Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart". Human & Experimental Toxicology 35, nr 6 (11.08.2015): 644–53. http://dx.doi.org/10.1177/0960327115597980.
Pełny tekst źródłaCope, Doris K., Keyser W. Impastato, Michael V. Cohen i James M. Downey. "Volatile Anesthetics Protect the Ischemic Rabbit Myocardium from Infarction". Anesthesiology 86, nr 3 (1.03.1997): 699–709. http://dx.doi.org/10.1097/00000542-199703000-00023.
Pełny tekst źródłaKe, Jianjuan, Bo Yao, Tao Li, Shanshan Cui i Huang Ding. "A2 Adenosine Receptor-mediated Cardioprotection Against Reperfusion Injury in Rat Hearts Is Associated With Autophagy Downregulation". Journal of Cardiovascular Pharmacology 66, nr 1 (lipiec 2015): 25–34. http://dx.doi.org/10.1097/fjc.0000000000000239.
Pełny tekst źródłaCappello, Sandra, Tommaso Angelone, Bruno Tota, Pasquale Pagliaro, Claudia Penna, Raffaella Rastaldo, Angelo Corti, Gianni Losano i Maria Carmela Cerra. "Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism". American Journal of Physiology-Heart and Circulatory Physiology 293, nr 1 (lipiec 2007): H719—H727. http://dx.doi.org/10.1152/ajpheart.01352.2006.
Pełny tekst źródłaLudwig, Lynda M., Hemal H. Patel, Garrett J. Gross, Judy R. Kersten, Paul S. Pagel i David C. Warltier. "Morphine Enhances Pharmacological Preconditioning by Isoflurane". Anesthesiology 98, nr 3 (1.03.2003): 705–11. http://dx.doi.org/10.1097/00000542-200303000-00019.
Pełny tekst źródłaRegan, Sara E., Michael Broad, Anne M. Byford, Amy R. Lankford, Rachael J. Cerniway, Marty W. Mayo i G. Paul Matherne. "A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity". American Journal of Physiology-Heart and Circulatory Physiology 284, nr 3 (1.03.2003): H859—H866. http://dx.doi.org/10.1152/ajpheart.00251.2002.
Pełny tekst źródłaThourani, Vinod H., Masanori Nakamura, Russell S. Ronson, James E. Jordan, Zhi-Qing Zhao, Jerrold H. Levy, Fania Szlam, Robert A. Guyton i Jakob Vinten-Johansen. "Adenosine A3-receptor stimulation attenuates postischemic dysfunction through KATP channels". American Journal of Physiology-Heart and Circulatory Physiology 277, nr 1 (1.07.1999): H228—H235. http://dx.doi.org/10.1152/ajpheart.1999.277.1.h228.
Pełny tekst źródłaXu, Fuqi, Shigang Qiao, Hua Li, Yanjun Deng, Chen Wang i Jianzhong An. "The Effect of Mitochondrial Complex I-Linked Respiration by Isoflurane Is Independent of Mitochondrial Nitric Oxide Production". Cardiorenal Medicine 8, nr 2 (2018): 113–22. http://dx.doi.org/10.1159/000485936.
Pełny tekst źródłaZhang, Ye, Michael G. Irwin, Tak Ming Wong, Mai Chen i Chun-Mei Cao. "Remifentanil Preconditioning Confers Cardioprotection via Cardiac κ- and δ-Opioid Receptors". Anesthesiology 102, nr 2 (1.02.2005): 371–78. http://dx.doi.org/10.1097/00000542-200502000-00020.
Pełny tekst źródłaKawabata, Ken-Ichi, Thomas Netticadan, Mitsuru Osada, Kohji Tamura i Naranjan S. Dhalla. "Mechanisms of ischemic preconditioning effects on Ca2+paradox-induced changes in heart". American Journal of Physiology-Heart and Circulatory Physiology 278, nr 3 (1.03.2000): H1008—H1015. http://dx.doi.org/10.1152/ajpheart.2000.278.3.h1008.
Pełny tekst źródłaLi, Yeli, Linying Feng, Dianyou Xie, Mu Lin, Yiqi Li, Nana Chen, Danli Yang, Jianmei Gao, Yizhun Zhu i Qihai Gong. "Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway". Antioxidants 11, nr 8 (27.07.2022): 1465. http://dx.doi.org/10.3390/antiox11081465.
Pełny tekst źródła